UTAH MEDICAL PRODUCTS INC (UTMD) — Institutional Holders, Q2 2026 (page 2)

116 institutional investment managers reported a UTMD position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $159.9M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 116. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

UTMD 13F holders ranked 101–116 of 116

Institutional investors reporting a position in UTAH MEDICAL PRODUCTS INC on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
True Wealth Design#101 · 28 sh$1.9K-6.7%
Farther Finance Advisors#102 · 27 sh$1.9K+170.0%
Quarry#103 · 27 sh$1.9KNew
Allworth Financial#104 · 23 sh$1.6K+130.0%
Cornerstone Planning Group#105 · 22 sh$1.5K+100.0%
NBC SECURITIES#106 · 19 sh$1.3KNew
Bare Financial Services#107 · 18 sh$1.2K-30.8%
Fortitude Family Office#108 · 15 sh$1.0K+50.0%
IFP Advisors#109 · 13 sh$897.00+8.3%
Hughes Financial Services#110 · 9 sh$621.000.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT#111 · 2 sh$138.00New
Optiver Holding B.V.#112 · 2 sh$138.00-92.3%
HUNTINGTON NATIONAL BANK#113 · 2 sh$138.000.0%
ROTHSCHILD INVESTMENT#114 · 2 sh$138.00+100.0%
BOK Financial Private Wealth#115 · 0 sh$78.00New
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#116 · 42 sh—-74.4%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.